ADC payload linker
6 listings from 6 suppliers
Japanese name: ADC薬物リンカー（ペイロード）
ADC payload-linkers combine a highly potent cytotoxic payload with the linker that joins it to an antibody, and they are used in the conjugation step that attaches drug to antibody. Most are supplied through contract synthesis under containment. Buyers therefore look at a provider's HPAPI handling capability, cleavable and non-cleavable linker options, and support for drug-to-antibody ratio (DAR) control. This page lists ADC materials and contract synthesis providers by maker.
| Product | Maker | Where to buy in Japan |
|---|---|---|
| ADC / bioconjugate contract services | Lonza | Not yet confirmed |
| ADC materials, linker/payload and contract synthesis | Merck | Merck Ltd., Japan (Japanese subsidiary, Life Science) |
| ADC development and manufacturing (linker-payload) | Sterling Pharma Solutions | Not yet confirmed |
| ADC / bioconjugation contract manufacturing | Catalent | Not yet confirmed |
| ADC linkers, payloads and linker-payload reagents | MedChemExpress | Not yet confirmed |
| ADC linker-payload CMC and contract services | Levena | Not yet confirmed |
“Where to buy in Japan” shows only sales relationships we have confirmed on the company’s or the distributor’s own website. “Not yet confirmed” means we have not checked yet, not that the product is unavailable in Japan. Product names link to the maker’s own page.